LY 203647

TargetMol
Product Code: TAR-T27893
Supplier: TargetMol
CodeSizePrice
TAR-T27893-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27893-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27893-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
LY 203647 is a antagonist of leukotriene D4 and E4 receptor.
CAS:
122009-61-4
Formula:
C21H30N8O3
Molecular Weight:
442.524
Purity:
0.98
SMILES:
CCCc1c(OCCCCc2nnn(CCCCc3nnn[nH]3)n2)ccc(C(C)=O)c1O

References

1. Mancuso G, Cusumano V, Cook JA, Smith E, Squadrito F, Blandino G, Teti G. Efficacy of tumor necrosis factor alpha and eicosanoid inhibitors in experimental models of neonatal sepsis. FEMS Immunol Med Microbiol. 1994 Jun;9(1):49-54. PubMed PMID: 7920463. 2. Passmore JC, Jimenez AE. Effectiveness of dual cyclooxygense and leukotriene blockade with ibuprofen and LY203647 during canine endotoxic shock. Circ Shock. 1993 Jan;39(1):21-8. PubMed PMID: 8481974. 3. Hahn RA, MacDonald BR, Morgan E, Potts BD, Parli CJ, Rinkema LE, Whitesitt CA, Marshall WS. Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury. J Pharmacol Exp Ther. 1992 Mar;260(3):979-89. PubMed PMID: 1312172. 4. Li EJ, Cook JA, Ashton S, Wise WC, Halushka PV. Effect of the LTD4 receptor antagonist LY203647 on endotoxic shock sequelae in the rat. Eur J Pharmacol. 1991 Jun 25;199(2):221-5. PubMed PMID: 1954979.